Avalyn Pharma Inc. (AVLN) Balance Sheet
As of 2026-06-30 (10-Q), Avalyn Pharma Inc. (AVLN) reported total assets of $425.4M, total liabilities of $27.1M and shareholders' equity of $398.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $264.2M. Long-term debt: $14.8M.
Source: SEC EDGAR filings · read by EquiReason
AVLNAvalyn Pharma Inc.Follow AVLN — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 22 days
Balance-sheet dates are not available for this company yet.
USD millions · SEC XBRL
Avalyn Pharma Inc. — questions
- How much cash does Avalyn Pharma Inc. have?
- $264.2M in cash and cash equivalents as of 2026-06-30.
- How much debt does Avalyn Pharma Inc. have?
- $14.8M of long-term debt as of 2026-06-30.
- What are Avalyn Pharma Inc.'s total assets?
- $425.4M as of 2026-06-30.
- What is Avalyn Pharma Inc.'s shareholders' equity?
- $398.3M as of 2026-06-30.
Every figure on this page comes from Avalyn Pharma Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.